Comparing two IVF medications for egg and embryo quality
Part of Women’s health & pregnancy clinical trials.
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 38 years old.
- You are planning to have your embryos genetically tested (PGT-A).
- Your body mass index (BMI) is between 18 and 30.
- You have a regular menstrual cycle (25 to 32 days).
- You and your partner agree to do two rounds of ovarian stimulation before moving to embryo transfer.
- You have no major womb issues, no endometriosis stage 3 or higher, and have had fewer than 2 miscarriages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial compares two hormone protocols for ovarian stimulation in women having their first cycle—either to freeze eggs for fertility preservation or for IVF with genetic testing. The goal is to see which method leads to more usable eggs while being easier on the patient.
This study compares two ways of giving fertility medication to stimulate the ovaries before retrieving eggs for IVF (in vitro fertilization). One method starts after ovulation and uses a drug called Elonva without a routine blocking medication, while the other is the standard approach starting early in the cycle. The goal is to see which approach leads to better outcomes for people undergoing IVF or ICSI (a procedure where a single sperm is injected into an egg).
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
Hear when a new OVARIAN STIMULATION trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.